InvestorsObserver
×
News Home

Is SpringWorks Therapeutics Inc (SWTX) a Leader in the Biotechnology Industry?

Monday, March 11, 2024 11:55 AM | InvestorsObserver Analysts

Mentioned in this article

Is SpringWorks Therapeutics Inc (SWTX) a Leader in the Biotechnology Industry?

SpringWorks Therapeutics Inc (SWTX) is near the top in its industry group according to InvestorsObserver. SWTX gets an overall rating of 71. That means it scores higher than 71 percent of stocks. SpringWorks Therapeutics Inc gets a 83 rank in the Biotechnology industry. Biotechnology is number 18 out of 148 industries.

Overall Score - 71
SWTX has an Overall Score of 71. Find out what this means to you and get the rest of the rankings on SWTX!

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 71 means the stock is more attractive than 71 percent of stocks.
Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With SpringWorks Therapeutics Inc Stock Today?

SpringWorks Therapeutics Inc (SWTX) stock is trading at $50.46 as of 11:50 AM on Monday, Mar 11, a drop of -$0.61, or -1.2% from the previous closing price of $51.07. The stock has traded between $50.42 and $52.47 so far today. Volume today is below average. So far 236,626 shares have traded compared to average volume of 1,473,845 shares. Click Here to get the full Stock Report for SpringWorks Therapeutics Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App